StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VBIO

Valion Bio, Inc.

VBIO Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.32
+0.04 +13.67%

Key statistics

from XBRL data in SEC filings
Market cap
$1.01M
Revenue (TTM)
$482K
Net income (TTM)
-$13.6M
EPS (TTM)
$-7.55
P/E ratio
Dividend yield
Free cash flow
-$7.04M
Cash
$7.21M
Total assets
$38.2M
Gross margin
-58.1%
52-week range
$0.25 – $5.60

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 14, 2026 8-K Unregistered sale of equity; Other events Jun 18, 2026 8-K Director or officer change; Shareholder vote results Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 8-K Director or officer change; Regulation FD disclosure May 4, 2026 8-K Amended charter or bylaws Apr 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 25, 2026 8-K Delisting notice or listing-rule failure Mar 20, 2026 8-K Entered a material agreement Mar 13, 2026 8-K Shareholder vote results; Other events Mar 11, 2026 8-K Director or officer change; Regulation FD disclosure Mar 4, 2026 8-K/A FORM 8-K AMENDMENT Feb 23, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 9, 2026 8-K Regulation FD disclosure Jan 20, 2026 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Dec 11, 2025 8-K Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Regulation FD disclosure Nov 14, 2025 8-K Other events Nov 13, 2025 8-K Director or officer change Oct 15, 2025 8-K Other events Aug 27, 2025 8-K Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 8-K/A Entered a material agreement Jul 25, 2025 8-K Director or officer change; Shareholder vote results Jul 7, 2025 8-K Entered a material agreement Jun 25, 2025 8-K Regulation FD disclosure Jun 25, 2025 8-K Regulation FD disclosure May 22, 2025 8-K Item 5.08; Other events May 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 8-K Entered a material agreement; Regulation FD disclosure May 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws May 2, 2025 8-K Other events Apr 22, 2025 8-K Other events Apr 14, 2025 8-K Regulation FD disclosure; Other events Apr 10, 2025 8-K Unregistered sale of equity; Other events Apr 3, 2025